Verition Fund Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $271K | Sell |
483
-251
| -34% | -$161K | ﹤0.01% | 1818 |
|
|
2025
Q4 | $497K | Sell |
734
-1,191
| -62% | -$811K | ﹤0.01% | 2661 |
|
|
2025
Q3 | $1.23M | Sell |
1,925
-15,978
| -89% | -$9.7M | 0.01% | 2367 |
|
|
2025
Q2 | $9.6M | Sell |
17,903
-44,858
| -71% | -$21.5M | 0.04% | 544 |
|
|
2025
Q1 | $26.4M | Buy |
62,761
+39,936
| +175% | +$17.3M | 0.12% | 145 |
|
|
2024
Q4 | $9.44M | Buy |
22,825
+16,317
| +251% | +$7.16M | 0.04% | 554 |
|
|
2024
Q3 | $3.29M | Buy |
6,508
+1,108
| +21% | +$538K | 0.02% | 1126 |
|
|
2024
Q2 | $2.63M | Sell |
5,400
-532
| -9% | -$267K | 0.01% | 1110 |
|
|
2024
Q1 | $3.2M | Sell |
5,932
-936
| -14% | -$512K | 0.02% | 958 |
|
|
2023
Q4 | $3.81M | Buy |
6,868
+4,690
| +215% | +$2.2M | 0.03% | 544 |
|
|
2023
Q3 | $952K | Buy |
2,178
+147
| +7% | +$73.3K | 0.01% | 1106 |
|
|
2023
Q2 | $1.02M | Buy |
2,031
+1,234
| +155% | +$591K | 0.01% | 923 |
|
|
2023
Q1 | $399K | Buy |
+797
| New | +$381K | 0.01% | 1372 |
|
|
2022
Q4 | – | Sell |
-4,311
| Closed | -$1.41M | – | 2415 |
|
|
2022
Q3 | $1.41M | Buy |
4,311
+2,435
| +130% | +$894K | 0.02% | 1152 |
|
|
2022
Q2 | $658K | Buy |
+1,876
| New | +$765K | 0.01% | 1270 |
|
|
2022
Q1 | – | Sell |
-1,595
| Closed | -$1.05M | – | 2864 |
|
|
2021
Q4 | $1.05M | Buy |
+1,595
| New | +$1M | 0.01% | 1269 |
|
|
2021
Q3 | – | Sell |
-555
| Closed | -$351K | – | 2097 |
|
|
2021
Q2 | $351K | Buy |
555
+46
| +9% | +$25.4K | ﹤0.01% | 1269 |
|
|
2021
Q1 | $249K | Buy |
+509
| New | +$255K | ﹤0.01% | 1220 |
|
|
2020
Q3 | – | Sell |
-1,185
| Closed | -$391K | – | 1209 |
|
|
2020
Q2 | $391K | Buy |
+1,185
| New | +$343K | 0.01% | 700 |
|
|
2019
Q4 | – | Sell |
-919
| Closed | -$250K | – | 1218 |
|
|
2019
Q3 | $250K | Buy |
+919
| New | +$256K | 0.01% | 871 |
|
|
2019
Q1 | – | Sell |
-3,227
| Closed | -$600K | – | 1195 |
|
|
2018
Q4 | $600K | Buy |
3,227
+1,327
| +70% | +$272K | 0.04% | 393 |
|
|
2018
Q3 | $474K | Buy |
1,900
+640
| +51% | +$155K | 0.02% | 859 |
|
|
2018
Q2 | $275K | Sell |
1,260
-2,540
| -67% | -$523K | 0.02% | 894 |
|
|
2018
Q1 | $727K | Buy |
3,800
+1,325
| +54% | +$245K | 0.05% | 497 |
|
|
2017
Q4 | $387K | Sell |
2,475
-4,874
| -66% | -$767K | 0.04% | 573 |
|
|
2017
Q3 | $1.14M | Buy |
7,349
+1,701
| +30% | +$269K | 0.09% | 264 |
|
|
2017
Q2 | $912K | Buy |
+5,648
| New | +$917K | 0.09% | 219 |
|
|
2017
Q1 | – | Sell |
-5,756
| Closed | -$675K | – | 1315 |
|
|
2016
Q4 | $675K | Buy |
5,756
+1,032
| +22% | +$118K | 0.06% | 405 |
|
|
2016
Q3 | $533K | Buy |
+4,724
| New | +$498K | 0.06% | 448 |
|
|
2016
Q2 | – | Sell |
-6,137
| Closed | -$481K | – | 956 |
|
|
2016
Q1 | $481K | Buy |
+6,137
| New | +$442K | 0.08% | 334 |
|
|
2015
Q4 | – | Sell |
-9,540
| Closed | -$708K | – | 506 |
|
|
2015
Q3 | $708K | Buy |
+9,540
| New | +$683K | 0.18% | 132 |
|
|
2015
Q1 | – | Sell |
-9,738
| Closed | -$722K | – | 444 |
|
|
2014
Q4 | $722K | Buy |
+9,738
| New | +$683K | 0.16% | 61 |
|
|
2014
Q3 | – | Sell |
-3,802
| Closed | -$254K | – | 799 |
|
|
2014
Q2 | $254K | Sell |
3,802
-1,080
| -22% | -$68.7K | 0.03% | 459 |
|
|
2014
Q1 | $296K | Buy |
+4,882
| New | +$291K | 0.05% | 278 |
|
Other funds holding IDXX
VCM
VPM
Verition Fund Management's IDXX Position: Q1 2026 in Review
Verition Fund Management reduced its Idexx Laboratories (IDXX) stake by 34% in Q1 2026, selling an estimated $161K and leaving 483 shares worth $271K. The position accounts for ﹤0.01% of the portfolio, ranked #1818.
Verition Fund Management first reported a position in IDXX in Q1 2014 and has held it in 34 quarters since. The position peaked at $26.4M in Q1 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Verition Fund Management held 483 shares of Idexx Laboratories worth $271K as of Q1 2026.
- Verition Fund Management sold 251 Idexx Laboratories shares in Q1 2026, an estimated $161K.
- Idexx Laboratories made up ﹤0.01% of Verition Fund Management's portfolio in Q1 2026, its #1818 holding.
- Verition Fund Management first reported a position in Idexx Laboratories in Q1 2014 and has held it in 34 quarters since.
- Verition Fund Management's Idexx Laboratories position peaked at $26.4M in Q1 2025.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.